Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer

BACKGROUND. The U.S. Food and Drug Administration-approved method for detecting EML4-ALK rearrangement is fluorescence in situ hybridization (FISH); however, data supporting the use of immunohistochemistry (IHC) for that purpose are accumulating. Previous studies that compared FISH and IHC considere...

詳細記述

保存先:
書誌詳細
出版年:Oncologist
主要な著者: Pekar-Zlotin, Marina, Hirsch, Fred R., Soussan-Gutman, Lior, Ilouze, Maya, Dvir, Addie, Boyle, Theresa, Wynes, Murry, Miller, Vincent A., Lipson, Doron, Palmer, Gary A., Ali, Siraj M., Dekel, Shlomi, Brenner, Ronen, Bunn, Paul A., Peled, Nir
フォーマット: Artigo
言語:Inglês
出版事項: AlphaMed Press 2015
主題:
Lung Cancer
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4350802/
https://ncbi.nlm.nih.gov/pubmed/25721120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0389
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料